Close
Almac
Achema middle east

Press Releases

GREENFIELD GLOBAL TAPS INDUSTRY VETERAN VEY GAROFALO TO DRIVE SPECIALTY CHEMICALS AND INGREDIENTS EXPANSION

Accomplished industry leader to continue driving growth and product expansion across life sciences, flavors, fragrances, and specialty segments Greenfield Global Inc., a leading global producer, manufacturer, and distributor of high-purity and specialty alcohols, solvents, and custom solutions, announced today the...

Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology.  CAMBRIDGE, UK, 08 July 2025 – Optibrium, a leading developer of software and AI solutions for molecular design, today announced it has...

Aptar CSP Technologies’ Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices

Dual-active material science solution is ideal for sensitive formulations Auburn, AL, July 8, 2025 – Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science, today announced that it has developed a dual-active material science technology...

datma Launches Federated Biomarker Explorer with Free Access to Help Pharma Validate Real-World Data Coverage

Pharma teams can now assess biomarker coverage across datma's federated network with no cost, contracts, or IT support required. datma, a leader in federated real-world data access, today announced the launch of the Federated Biomarker Explorer, a new application that allows...

Infudopa SubC Parkinsons Therapy: Neuraxpharm-Dizlin Deal

Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company dedicated to central nervous system (CNS) disorders, and Dizlin Pharmaceuticals AB (“Dizlin”), a Swedish R&D company focused on late-stage Parkinsons disease (PD), today announced a strategic global co-development agreement for...

HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER

Haleon today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025. This appointment follows Franck Riot deciding to leave Haleon after six years in the business. Carl joins Haleon from...

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines

London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »